Dimitri P Mikhailidis Selected Research

Hydroxymethylglutaryl-CoA Reductase Inhibitors (HMG-CoA Reductase Inhibitors)

7/2022	Benefits and drawbacks of statins and non-statin lipid lowering agents in carotid artery disease.
1/2022	Statins and diabetes mellitus progression: a fly in the ointment?
1/2022	Relationship between low-density lipoprotein cholesterol, lipid-lowering agents and risk of stroke: a meta-analysis of observational studies (n = 355,591) and randomized controlled trials (n = 165,988).
1/2022	Effects of statins on specialized pro-resolving mediators: An additional pathway leading to resolution of inflammation.
1/2022	Clinical benefit of statin treatment on patients with non-alcoholic fatty liver disease or steatohepatitis.
12/2021	Statin use and renal function after aortic aneurysm repair procedures.
1/2021	Can We Decrease Epicardial and Pericardial Fat in Patients With Diabetes?
1/2021	The effect of statins on semen parameters in patients with hypercholesterolemia: A systematic review.
1/2021	More Good News on Statins and COVID-19.
1/2021	Have We Learnt all from IMPROVE-IT? Part I. Core Results and Subanalyses on the Effects of Ezetimibe Added to Statin Therapy Related to Age, Gender and Selected Chronic Diseases (Kidney Disease, Diabetes Mellitus and Non-Alcoholic Fatty Liver Disease).

For more, sign up at right for free...

Join CureHunter, for free Research Interface BASIC access!

Take advantage of free CureHunter research engine access to explore the best drug and treatment options for any disease. Find out why thousands of doctors, pharma researchers and patient activists around the world use CureHunter every day.

Realize the full power of the drug-disease research graph!

Dimitri P Mikhailidis Research Topics

Disease

69	Cardiovascular Diseases (Cardiovascular Disease) 01/2022 - 05/2002
47	Hypertension (High Blood Pressure) 01/2022 - 01/2002
47	Coronary Disease (Coronary Heart Disease) 12/2020 - 01/2002
44	Atherosclerosis 01/2022 - 01/2002
43	Stroke (Strokes) 11/2022 - 01/2003
43	Metabolic Syndrome (Dysmetabolic Syndrome X) 01/2018 - 01/2005
41	Inflammation (Inflammations) 01/2022 - 03/2006
39	Non-alcoholic Fatty Liver Disease 01/2022 - 05/2006
32	Obesity 01/2021 - 08/2005
32	Dyslipidemias (Dyslipidemia) 01/2020 - 05/2002
29	Type 2 Diabetes Mellitus (MODY) 12/2020 - 09/2003
28	Heart Failure 01/2022 - 03/2006
28	Insulin Resistance 01/2021 - 09/2003
28	Vascular Diseases (Vascular Disease) 07/2018 - 01/2003
24	Chronic Renal Insufficiency 01/2020 - 05/2009
22	Peripheral Arterial Disease 01/2022 - 04/2003
19	Diabetes Mellitus 01/2022 - 01/2003
17	Coronary Artery Disease (Coronary Atherosclerosis) 01/2022 - 01/2003
17	Body Weight (Weight, Body) 12/2020 - 01/2004
16	Myocardial Infarction 07/2022 - 01/2003
15	Carotid Stenosis (Carotid Artery Stenosis) 07/2022 - 03/2007
14	Neoplasms (Cancer) 01/2020 - 10/2006
13	Acute Coronary Syndrome 01/2021 - 01/2005
12	Hypercholesterolemia 01/2021 - 10/2002
11	Hyperlipidemias (Hyperlipidemia) 01/2018 - 09/2006
10	Abdominal Aortic Aneurysm 07/2018 - 08/2007
9	Carotid Artery Diseases 07/2022 - 08/2007
9	Thrombosis (Thrombus) 07/2018 - 01/2005
8	Fatty Liver 01/2022 - 12/2011
8	Erectile Dysfunction 01/2022 - 01/2002
8	Ischemic Stroke 01/2022 - 01/2003
8	Atherosclerotic Plaque (Atheroma) 01/2015 - 01/2003
7	Transient Ischemic Attack 07/2022 - 01/2007
7	Hemorrhage 04/2022 - 02/2006
7	Atrial Fibrillation 01/2022 - 03/2006
7	Abdominal Obesity 11/2017 - 07/2005
7	Alcoholic Fatty Liver 01/2017 - 08/2012
6	Essential Hypertension 02/2014 - 04/2005
6	Hypertriglyceridemia 01/2012 - 09/2003
5	Unstable Angina 01/2021 - 11/2007
5	Weight Loss (Weight Reduction) 01/2020 - 05/2007
5	Acute Kidney Injury (Acute Renal Failure) 01/2018 - 01/2008
5	Ischemia 03/2010 - 01/2006
5	Prostatic Neoplasms (Prostate Cancer) 01/2010 - 09/2004

Drug/Important Bio-Agent (IBA)

130	Hydroxymethylglutaryl-CoA Reductase Inhibitors (HMG-CoA Reductase Inhibitors)IBA 07/2022 - 07/2002
75	LipidsIBA 07/2022 - 01/2002
36	Triglycerides (Triacylglycerol)IBA 12/2020 - 10/2002
33	Atorvastatin (Lipitor)FDA Link 01/2014 - 01/2002
30	CholesterolIBA 11/2021 - 04/2004
27	oxidized low density lipoproteinIBA 07/2022 - 01/2002
26	HDL CholesterolIBA 01/2019 - 01/2002
23	Uric Acid (Urate)IBA 09/2021 - 04/2004
22	LDL CholesterolIBA 07/2022 - 01/2002
22	Glucose (Dextrose)FDA LinkGeneric 11/2021 - 07/2005
21	C-Reactive ProteinIBA 01/2022 - 05/2002
18	Ezetimibe (Zetia)FDA Link 07/2022 - 10/2006
17	Pharmaceutical PreparationsIBA 01/2021 - 08/2005
14	Biomarkers (Surrogate Marker)IBA 01/2021 - 05/2006
12	Lipoprotein(a)IBA 01/2022 - 07/2005
12	Insulin (Novolin)FDA Link 01/2018 - 01/2008
11	Lipoproteins (Lipoprotein)IBA 01/2021 - 01/2005
11	ApolipoproteinsIBA 01/2020 - 01/2003
9	Simvastatin (Zocor)FDA LinkGeneric 01/2021 - 01/2003
9	AdipokinesIBA 01/2021 - 12/2007
9	Fibrinogen (Factor I)FDA Link 02/2019 - 09/2003
9	AntioxidantsIBA 12/2018 - 01/2006
8	Proteins (Proteins, Gene)FDA Link 01/2022 - 03/2009
8	Hypoglycemic Agents (Hypoglycemics)IBA 11/2021 - 08/2010
8	Vitamin D FDA LinkGeneric 05/2019 - 10/2010
8	LeptinIBA 07/2018 - 06/2006
8	Rosuvastatin Calcium (Crestor)FDA Link 07/2015 - 06/2006
7	Indicators and Reagents (Reagents)IBA 07/2016 - 06/2002
7	HDL LipoproteinsIBA 01/2016 - 07/2005
7	LDL Lipoproteins (beta Lipoproteins)IBA 01/2014 - 01/2007
6	CreatinineIBA 12/2022 - 10/2008
6	Fibric Acids (Fibrates)IBA 07/2022 - 01/2009
6	Clopidogrel (Plavix)FDA Link 01/2022 - 04/2003
6	AdiponectinIBA 08/2017 - 05/2007
6	Platelet Aggregation Inhibitors (Antiplatelet Drugs)IBA 10/2014 - 03/2004
6	Fenofibrate (CiL)FDA LinkGeneric 12/2013 - 01/2005
6	Serotonin (5 Hydroxytryptamine)IBA 05/2013 - 11/2005
6	Adenosine Triphosphate (ATP)IBA 01/2012 - 01/2005
6	Antihypertensive Agents (Antihypertensives)IBA 07/2011 - 01/2002
5	Aspirin (Acetylsalicylic Acid)FDA LinkGeneric 01/2022 - 03/2004
5	CytokinesIBA 01/2021 - 07/2013
5	Blood Glucose (Blood Sugar)IBA 01/2019 - 11/2005
5	BilirubinIBA 05/2016 - 02/2009
5	GhrelinIBA 04/2013 - 01/2011
5	Hormones (Hormone)IBA 04/2013 - 09/2004
5	Metformin (Glucophage)FDA LinkGeneric 01/2012 - 05/2006
5	Orlistat (Xenical)FDA Link 11/2011 - 05/2006
5	Apolipoproteins E (ApoE)IBA 01/2009 - 01/2003
4	AlbuminsIBA 01/2022 - 01/2013

Therapy/Procedure

52	Therapeutics 01/2022 - 05/2002
12	Carotid Endarterectomy 11/2022 - 03/2007
10	Secondary Prevention 09/2021 - 05/2005
10	Percutaneous Coronary Intervention 01/2019 - 02/2006
8	Glycemic Control 01/2020 - 05/2007
7	Drug Therapy (Chemotherapy) 01/2020 - 08/2009
6	Vascular Surgical Procedures 11/2022 - 09/2010